MAPK1 and central nervous system cancer: But the p-p38/MAPK inhibitor had no effect on reversing the function of circ-MAPK4 in the invasive ability of glioma cells (Additional file 5: Figure S4), which suggested that circ-MAPK4 might regulate cell invasion through another signaling pathway.